Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License

  • n. A monoclonal antibody and antineoplastic that binds to EGFR, under investigation for the treatment of cancer.

Etymologies

from Wiktionary, Creative Commons Attribution/Share-Alike License

-tum- +‎ -u- +‎ -mab

Examples

  • But Erbitux sales have slowed after the discovery that it wasn't effective in people with a certain genetic profile, and Lilly and partner Bristol-Myers Squibb Co. recently halted a late-stage trial of experimental cancer drug necitumumab because of safety concerns.

    Sanofi Needs to Avoid Pitfalls of Pharma-Biotech Deals

  • The companies said they will continue to study necitumumab, which has no approved use, in a separate late-stage study that combines it with Lilly's Gemzar and cisplatin to treat another form of lung cancer.

  • INDIANAPOLIS AP -- Drugmakers Eli Lilly and Co. and Bristol-Myers Squibb Co. said Wednesday they stopped enrolling patients in one of two late-stage studies of the potential cancer treatment necitumumab due to concerns about blood clots.

  • Bristol-Myers stopped one of two late-stage studies of its biologic drug for non-small cell lung cancer, necitumumab, in February after signs of increased risk of dangerous blood clots.

    Yahoo! News: Business - Opinion

  • Under the restructured agreement, both companies will share in the cost of developing and potentially commercializing necitumumab in the U.S.,

    THE MEDICAL NEWS

  • As restructured, both companies will share in the cost of developing and potentially commercializing necitumumab in the U.S.,

    StreetInsider.com News Articles

  • Lilly maintains exclusive rights to necitumumab in all other markets.

    StreetInsider.com News Articles

  • The company restructured the collaboration agreement executed by Bristol-Myers Squibb and ImClone in 2001 to allow for the co-development and co-commercialization of the late-stage oncology molecule necitumumab (IMC-11F8), which is currently in Phase III clinical testing for non-small cell lung cancer.

    THE MEDICAL NEWS

  • As John mentioned earlier in January November Lilly and Bristol-Myers Squibb restructured our existing collaboration agreement to allow for the co-development and co-commercialization of necitumumab, or IMC11F8 which is currently in phase III clinical trials for non-small scale lung cancer.

    SeekingAlpha.com: Home Page

  • Lilly and BMS will share the cost of developing and potentially commercializing necitumumab in the US, Canada and Japan.

    SeekingAlpha.com: Home Page

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.